Skip to content

Zai Lab Ltd Sustainability Reports

Zai Lab Limited is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs. Its core therapeutic areas include oncology, immunology, neuroscience, and infectious diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 549300P2UYQ9U5LY1T58

FIGI: BBG00BVB6SB6

11 reports from 2020 to 2025